Lack of functional selectin ligand interactions compromises long term tumor protection by CD8 + T cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Stark, Felicity C ^a   Gurnani, Komal ^b   Sad, Subash ^a,b   Krishnan, Lakshmi ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; SELECTIN; TUMOR ANTIGEN; FUCOSYLTRANSFERASE; LIGAND; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR XENOGRAFT; WILD TYPE; ANIMAL; ANTIGEN PRESENTATION; IMMUNOLOGY; MOUSE MUTANT; NEOPLASM;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; FUCOSYLTRANSFERASES; LIGANDS; MICE; MICE, KNOCKOUT; NEOPLASMS; OVALBUMIN; SELECTINS;

EID: 84857124598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032211     Document Type: Article

References (47)

1. Klebanoff CA, Acquavella N, Yu Z, Restifo NP, (2011) Therapeutic cancer vaccines: are we there yet? Immunol Rev 239: 27-44.
2. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, et al. (2001) Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 167: 6471-6479.
3. Paterson Y, Guirnalda PD, Wood LM, (2010) Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy. Semin Immunol 22: 183-189.
4. Tangney M, Gahan CG, (2010) Listeria monocytogenes as a vector for anti-cancer therapies. Curr Gene Ther 10: 46-55.
5. Liu MA, (2010) Immunologic basis of vaccine vectors. Immunity 33: 504-515.
6. Liu L, Wang S, Shan B, Sang M, Liu S, et al. (2010) Advances in viral-vector systemic cytokine gene therapy against cancer. Vaccine 28: 3883-3887.
7. Sad S, Krishnan L, (2003) Maintenance and attrition of T-cell memory. Crit Rev Immunol 23: 129-147.
8. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
9. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 401: 708-712.
10. Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, et al. (2005) Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 102: 9571-9576.
11. Hinrichs CS, Gattinoni L, Restifo NP, (2006) Programming CD8+ T cells for effective immunotherapy. Curr Opin Immunol 18: 363-370.
12. Wang X, Berger C, Wong CW, Forman SJ, Riddell SR, et al. (2011) Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice. Blood 117: 1888-1898.
13. Stark FC, Sad S, Krishnan L, (2009) Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection. Cancer Res 69: 4327-4334.
14. Springer TA, (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
15. Patel KD, Cuvelier SL, Wiehler S, (2002) Selectins: critical mediators of leukocyte recruitment. Semin Immunol 14: 73-81.
16. Easton EW, Schiphorst WE, van Drunen E, van der Schoot CE, van den Eijnden DH, (1993) Human myeloid alpha 3-fucosyltransferase is involved in the expression of the sialyl-Lewis(x) determinant, a ligand for E- and P-selectin. Blood 81: 2978-2986.
17. Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, et al. (1996) The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86: 643-653.
18. Ley K, Kansas GS, (2004) Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 4: 325-335.
19. Harp JR, Gilchrist MA, Onami TM, (2010) Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice. J Immunol 185: 5751-5761.
20. Harp JR, Onami TM, (2010) Naive T cells re-distribute to the lungs of selectin ligand deficient mice. PLoS One 5: e10973.
21. Wirth TC, Badovinac VP, Zhao L, Dailey MO, Harty JT, (2009) Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodes. J Immunol 182: 6195-6206.
22. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, et al. (2002) Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 195: 1523-1532.
23. Obar JJ, Lefrancois L, (2010) Memory CD8+ T cell differentiation. Ann N Y Acad Sci 1183: 251-266.
24. Brinkman CC, Sheasley-O'Neill SL, Ferguson AR, Engelhard VH, (2007) Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics. Journal Of Immunology 181: 1814-1824.
25. Homeister JW, Thall AD, Petryniak B, Maly P, Rogers CE, et al. (2001) The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 15: 115-126.
26. Cai YH, Alvarez A, Alcaide P, Duramad P, Lim YC, et al. (2006) Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart. J Immunol 176: 6568-6575.
27. Smithson G, Rogers CE, Smith PL, Scheidegger EP, Petryniak B, et al. (2001) Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes. J Exp Med 194: 601-614.
28. Jones TR, Shirasugi N, Adams AB, Pearson TC, Larsen CP, (2003) Intravital microscopy identifies selectins that regulate T cell traffic into allografts. J Clin Invest 112: 1714-1723.
29. Luangsay S, Kasper LH, Rachinel N, Minns LA, Mennechet FJ, et al. (2003) CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology 125: 491-500.
30. Kershaw MH, Wang G, Westwood JA, Pachynski RK, Tiffany HL, et al. (2002) Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. Hum Gene Ther 13: 1971-1980.
31. Sasaki K, Zhao X, Pardee AD, Ueda R, Fujita M, et al. (2008) Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J Immunol 181: 104-108.
32. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213.
33. Naito Y, Saito K, Shiiba K, Ohuchi A, Seigenji K, et al. (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494.
34. Rosenberg SA, Dudley ME, (2009) Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21: 233-240.
35. Ehlers S, Schreiber T, Dunzendorfer A, Lowe JB, Holscher C, (2009) Fucosyltransferase IV and VII-directed selectin ligand function determines long-term survival in experimental tuberculosis. Immunobiology 214: 674-682.
36. Erdmann I, Scheidegger EP, Koch FK, Wagner H, Heeg K, (2002) Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 168: 2139-2146.
37. Klebanoff CA, Gattinoni L, Restifo NP, (2006) CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211: 214-224.
38. Spertini O, Cordey AS, Monai N, Giuffre L, Schapira M, (1996) P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells. J Cell Biol 135: 523-531.
39. Schuster K, Gadiot J, Andreesen R, Mackensen A, Gajewski TF, et al. (2009) Homeostatic proliferation of naive CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LN. Eur J Immunol 39: 2981-2990.
40. Arbones ML, Ord DC, Ley K, Ratech H, Maynard-Curry C, et al. (1994) Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1: 247-260.
41. Stekel DJ, (1998) The simulation of density-dependent effects in the recirculation of T lymphocytes. Scand J Immunol 47: 426-430.
42. Ferguson AR, Engelhard VH, (2010) CD8 T cells activated in distinct lymphoid organs differentially express adheshion proteins and coexpress multiple chemokine receptors. Journal Of Immunology 184: 4079-4086.
43. Morgan RA, Dudley ME, Wunderlich JR, Hughes MH, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
44. Eshhar Z, Waks T, Gross G, Schindler DG, (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A 90: 720-724.
45. Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, et al. (2005) Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J Immunol 174: 4415-4423.
46. Dudani R, Chapdelaine Y, Faassen HvH, Smith DK, Shen H, et al. (2002) Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J Immunol 168: 5737-5745.
47. Barber DL, Wherry EJ, Ahmed R, (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171: 27-31.